COA
Certificate of Analysis
Third-party HPLC and MS testing for every batch, published before purchase and tied to the batch being sold.
HPLC / MS
Endocrine Research
CJC-1295 + Ipamorelin10mg
GHRH analog plus ghrelin-receptor secretagogue blend for GH-axis research.
$75per vial
Product handling note
Lyophilized powder may shift or come loose during transit; that is a normal occurrence and does not affect the integrity of the research product. Fill appearance and batch-specific details may vary. Refer to the Certificate of Analysis below for the documentation tied to the current batch.
Research overview
Why researchers study paired GH-axis secretagogues.
CJC-1295 and Ipamorelin sit in adjacent GH-axis research lanes. CJC-1295 is discussed as a long-acting GHRH analog, while Ipamorelin is discussed as a selective growth hormone secretagogue tied to the ghrelin / GHS receptor pathway.
The reason to list the pair clearly is that the blend is not one vague "growth" product. It is a two-component research material with two receptor contexts, one labeled strength, and one batch record that should make the component identity easy to verify.
The receipts
What you get with every vial.
ID
Batch traceability
Every vial is stamped with a batch ID that links back to its COA, source record, and current product documentation.
Batch linkedLabel
Batch-linked labeling
Product identity, strength, and batch reference stay easy to match from the product listing to the vial in hand.
Listing to vialRelated peptides
Adjacent research lanes.
Product FAQ
Common research questions.
Why pair a GHRH analog with Ipamorelin?
The research logic is receptor context. CJC-1295 is read through the GHRH lane, while Ipamorelin is read through the ghrelin / GHS receptor lane. The pair gives a clear two-component comparison point.
Why does the dose show 10mg?
The catalog presents the vial as 10mg total while the research context still makes clear that this is a paired CJC-1295 and Ipamorelin material.
How is this different from Tesamorelin?
Tesamorelin is a single GHRH analog lane. CJC-1295 + Ipamorelin is a paired GHRH analog plus secretagogue lane, so the component context is different.
What should the batch record prove?
It should connect both component identities, the 10mg total strength, purity or assay results, batch code, and COA to the exact vial lot.
Research sources
Literature links are included for background reading. Batch-specific identity and purity details live in the COA tied to the current batch.